Wyszukaj projekt badawczy
36 Wyniki
Ufundowane przez członka IRDiRC = 
Projekt badawczy
WŁOCHY
LOMBARDIA
MILANO
Valutazione della secrezione dell'ormone della crescita e riserva surrenale, in parallelo con paramentri cardiaci ed ossei in pazienti adulti con Talassemia
IRCCS Istituto Auxologico Italiano
Dipartimento di Endocrinologia e Malattie del Ricambio
FINLANDIA
Finland
HELSINKI
Genomic editing for treating hemoglobin diseases
University of Helsinki
Stem Cells and Metabolism Research Program
FRANCJA
ILE-DE-FRANCE
PARIS
Maladies hématologiques constitutionnelles: recherche clinique, thérapeutique; biologie moléculaire
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Service d'hématologie pédiatrique
FRANCJA
ILE-DE-FRANCE
PARIS
GETH : L'Édition Génomique comme outil Thérapeutique contre les ß-Hémoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Equipe "Chromatine et régulation des gènes au cours du développement"
FRANCJA
ILE-DE-FRANCE
PARIS
TIEBET: Signalisation TGF-Beta et l'érythropoïèse inefficace dans la bêta-thalassémie - FR
IMAGINE - Institut des Maladies Génétiques
Laboratoire des mécanismes moléculaires des troubles hématologiques et implications thérapeutiques
WŁOCHY
EMILIA ROMAGNA
FERRARA
Modificatori dell'espressione di geni globinici per il trattamento terapeutico della beta-talassemia
Università degli Studi di Ferrara
Laboratorio di Biologia Molecolare dell'Emostasi e Trombosi
WŁOCHY
LOMBARDIA
BRESCIA
Nuovi approcci farmacologici per disordini genetici dell'epcidina
ASST Spedali Civili di Brescia
Laboratorio di Medicina Molecolare
WŁOCHY
LOMBARDIA
MILANO
Studio sulla sicurezza dei vettori
IRCCS Ospedale San Raffaele
Centro di Genomica, Bioinformatica e Biostatistica - Unità di Genetica Umana e Molecolare
WŁOCHY
LOMBARDIA
MILANO
Terapia genica per la beta talassemia
Istituto San Raffaele Telethon per la Terapia Genica - TIGET
Istituto San Raffaele Telethon per la Terapia Genica
WŁOCHY
SARDEGNA
MONSERRATO
Validazione del gene delta globinico umano quale target terapeutico per la beta talassemia e l'anemia falciforme
IRGB CNR - Istituto di Ricerca Genetica e Biomedica
Gruppo di Ricerca per la Talassemia
HOLANDIA
Zuid-Holland
ROTTERDAM
THALAMOSS: THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia - NL
Erasmus MC - Erasmus Medisch Centrum
Afdeling Celbiologie
HOLANDIA
Zuid-Holland
ROTTERDAM
THALAMOSS: THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia - NL
Erasmus MC - Erasmus Medisch Centrum
Harbour Antibodies BV
RUMUNIA
BUCURESTI
BUCURESTI
Identificarea si caracterizarea moleculara a mutatiilor care codifica lantul beta - globinei la pacientii cu talasemie din romania
Fundeni Clinical Institute
Department of Hematology
STANY ZJEDNOCZONE AMERYKI
Washington
ADDRESS: NOT PROVIDED - US
Repurposing an eu therapeutic for hemoglobinopathies
Institution: Information not provided - US
WŁOCHY
PUGLIA
BARI
DEEP - Valutazione del deferiprone nei pazienti pediatrici
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF)
Consorzio per Valutazioni Biologiche e Farmacologiche
PORTUGALIA
SUL
LISBOA
Investigação Molecular em Hemoglobinopatias
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Departamento de Genética
HOLANDIA
Utrecht
UTRECHT
CoMMiTMenT: Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments - NL
UMC Utrecht - Universitair Medisch Centrum Utrecht
Laboratorium voor Rode Bloedcel Onderzoek
KANADA
Ontario
TORONTO
Inherited bone marrow failure syndromes: from genomic discoveries to biology
Hospital for Sick Children, Research Institute
FRANCJA
ILE-DE-FRANCE
PARIS
STaHR : Stimulation de la Recombinaison Homologue pour la Thérapie Génique - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
FRANCJA
PAYS DE LA LOIRE
NANTES
FROGH : Etude Génétique de la Population Française - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
WŁOCHY
CAMPANIA
NAPOLI
Programma Telethon per le malattie senza diagnosi
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine
JAPONIA
JAPAN
AICHI
Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University
JAPONIA
JAPAN
AICHI
Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University
JAPONIA
JAPAN
TOKYO
Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development
Research Institute
Wieloośrodkowy projekt badawczy
- The Cyprus Institute of Neurology and Genetics
- Department of molecular genetics A
- IMAGINE - Institut des Maladies Génétiques
- Laboratoire des mécanismes moléculaires des troubles hématologiques et implications thérapeutiques
- University of Athens - Medical school
- Laboratory of Biology
- University of Athens - Medical school
- Laboratory of Biology
- Università degli Studi di Ferrara
- Laboratorio di Biologia Molecolare dell'Emostasi e Trombosi
- Università degli Studi di Bari Aldo Moro
- Dipartimento Integrato di Medicina
- Universitätsklinikum des Saarlandes
- Institut für Molekulare Zellbiologie
- Institution: Information not provided - ES
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- Muséum National d'Histoire Naturelle
- Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
- Institut de Recherche en Santé - Université de Nantes
- L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
CYPR
Cyprus
NICOSIA
ITHANET: réseau euro-méditerranéen des centres de recherche conduisant des recherches moléculaire et clinique sur la thalassémie et autres formes d'hémoglobinopathies
FRANCJA
ILE-DE-FRANCE
PARIS
TIEBET: Signalisation TGF-Beta et l'érythropoïèse inefficace dans la bêta-thalassémie
GRECJA
ATTIKI
ATHENS
GETHERTHAL: improvements of vector techology and safety for the gene therapy of thalassemia
GRECJA
ATTIKI
ATHENS
GETHERTHALPLUS: Novel Gene Therapy for Thalassemia: Pre-clinical Development and Assessment in Animal and Stem Cell Models
WŁOCHY
EMILIA ROMAGNA
FERRARA
THALAMOSS: THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia
WŁOCHY
PUGLIA
BARI
DEEP: Valutazione sull'uso pediatrico del deferiprone
NIEMCY
Saarland
HOMBURG
CoMMiTMenT: Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments
HISZPANIA
Madrid
ADDRESS: NOT PROVIDED - ES
E-Enerca: New E-Health Services For The European Reference Network On Rare Anaemias
KANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
FRANCJA
ILE-DE-FRANCE
PARIS
STaHR : Stimulation de la Recombinaison Homologue pour la Thérapie Génique
FRANCJA
PAYS DE LA LOIRE
NANTES
FROGH : Etude Génétique de la Population Française
WŁOCHY
LAZIO
ROMA